Mangumpit, Max Kaiden .

HRN: 21-94-28  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/29/2025
08/05/2025
TOPICAL
1ml
QID
Oral Ulcers
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: